United States
Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
ICU Medical Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
44930G107
(CUSIP number)
12/31/2004
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[ X ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person?s initial filing on this
form with respect to the subject class of securities, and for any
subsequent amendment containing
information which would alter the disclosures provided in a prior
cover page.
The information required in the remainder of this cover page shall
not be deemed to be ?filed? for
the purpose of Section 18 of the Securities Exchange Act of 1934 (?Act?)
or otherwise subject to
the liabilities of that section of the Act but shall be subject to
all other provisions of the Act
(however, see the Notes.)
CUSIP No. 44930G107
1 - NAME OF REPORTING PERSON
Eaton Vance Corp.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
04-2718215
2 - CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b) Group Disclaimed _X_
3 - SEC USE ONLY
4 - CITIZENSHIP OR PLACE OF ORGANIZATION
Boston, MA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
5 - SOLE VOTING POWER 635,161 Shares
6 - SHARED VOTING POWER 0 Shares
7 - SOLE DISPOSITIVE POWER 635,161 Shares
8 - SHARED DISPOSITIVE POWER 0 Shares
9 - AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
635,161 Shares
10 - CHECK IF THE AGGREGATE AMOUNT ON ROW (9) EXCLUDES CERTAIN SHARES
11 - PERCENT OF CLASS REPRESENTED BY AMOUNT ON ROW 9
4.7%
12 - TYPE OF REPORTING PERSON
IA
CUSIP No. 44930G107
Item 1(a) Name of Issuer:
ICU Medical Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
951 Calle Amanecer
San Clemente, CA 92673
Item 2(a) Name of Person Filing:
Eaton Vance Corp.
Item 2(b) Address of Principal Business Office of Person Filing:
255 State Street
Boston, MA 02109
Item 2(c) Citizenship:
United States
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
44930G107
Item 3 Eligibility to File Schedule 13G:
Eaton Vance Corp. is an investment adviser in accordance with
S240.13d-1(b)(1)(ii)(E).
Item 4 Ownership:
(a) Amount beneficially owned: 635,161 Shares
(b) Percent of class: 4.7%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote of 635,161 Shares.
(ii) Shared power to vote or to direct the vote 0 shares.
(iii) Sole power to dispose or to direct the disposition of 635,161 Shares.
(iv) Shared power to dispose or to direct the disposition of 0 shares.
Item 5 Ownership of Five Percent or Less of a Class:
Eaton Vance Corp., as of the date hereof, has ceased to be
beneficial owner more than 5
percent of ICU Medical Inc.
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
Not applicable
Item 7 Identification and Classification of the Subsidiary, which A
cquired the Security Being
reported on by the Parent Holding Company:
Not applicable
Item 8 Identification and Classification of Members of the Group:
Not applicable
Item 9 Notice of Dissolution of Group:
Not applicable
Item 10 Certification:
CERTIFICATION AND SIGNATURE
By signing below, I certify that, to the best of my knowledge and belief,
the securities referred to
above were acquired and are held in the ordinary course of business and
were not acquired and are
not held for the purpose of or with the effect of changing or influencing
the control of the issuer of
the securities and were not acquired and are not held in connection with
or as a participant in any
transaction having that purpose or effect.
After reasonable inquiry and to the best of its knowledge and belief,
I certify that the information
set forth in this statement is true, complete and correct.
EATON VANCE MANAGEMENT
By: /s/Michelle A. Green
(Signature)
Michelle A. Green, Vice President
02/14/2005
(Date)